Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shaogeng Chen"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundSegmentectomy has been proven to have better survival and perioperative efficacy than lobectomy for non-small cell lung cancer (NSCLC) up to 2 cm. Whether this result is applicable to stage T1cN0M0 NSCLC (2.1 to 3 cm) remains controversial.
Externí odkaz:
https://doaj.org/article/55fd8f4ec3054f53819099b072e0f8ef
Publikováno v:
Journal of Thoracic Disease. 15:1302-1318
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::351a19ed4039d4933faf105f604bcbf3
https://doi.org/10.21037/jtd-23-143
https://doi.org/10.21037/jtd-23-143
Publikováno v:
Journal of Oncology. 2022:1-16
Esophageal squamous cell carcinoma (ESCC) has still been considered to be the most common malignant tumors in China. Emerging evidence indicates that cysteinyl-tRNA synthetase 1 (CARS1) has been considered as a ferroptosis-related gene in ESCC. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::807c32dce154578590919e624a91b912
https://doi.org/10.1155/2022/4849174
https://doi.org/10.1155/2022/4849174
Publikováno v:
Chemosphere. 308(Pt 2)
Although microbially induced carbonate precipitation (MICP) technology effectively promotes the remediation of heavy metal contaminated soils in low concentrations, the high concentration of heavy metals has a toxic effect on microorganisms, which le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e3988d7a1a4503e8e193e52e8528052
https://pubmed.ncbi.nlm.nih.gov/36113657
https://pubmed.ncbi.nlm.nih.gov/36113657
Publikováno v:
Experimental Cell Research. 426:113567
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a2aadd495daab14d3b9ed8efb8a88b0
https://doi.org/10.1016/j.yexcr.2023.113567
https://doi.org/10.1016/j.yexcr.2023.113567
Autor:
Yi Zhang, Guoyi Shen, Rongyu Xu, Guozhong Huang, Shengsheng Yang, Qingfeng Zheng, Zhijun Huang, Hongbing Duan, Liangyun Ma, Libao Yang, Yunfeng Yi, Rongxing Liu, Kezhi Li, Shaogeng Chen
Publikováno v:
Journal of Clinical Oncology. 40:250-250
250 Background: Camrelizumab, a fully humanized monoclonal anti-PD-1 antibody, has shown promising efficacy with good tolerance in neoadjuvant therapy of resectable locally advanced esophageal cancer (EC). The present study aimed to investigate the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9ec46e3af467951fe717acced8eb93b
https://doi.org/10.1200/jco.2022.40.4_suppl.250
https://doi.org/10.1200/jco.2022.40.4_suppl.250
Publikováno v:
Biomedical Research. 29
Objective: As a common malignant tumor, esophageal carcinoma lacked specific clinical symptoms, leading to distal metastasis at terminal stage. Cisplatin is the first-line chemotherapy drug for the treatment of esophageal cancer. Identification of se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c7c5f06a8fe5d493281c2c6c528c423
https://doi.org/10.4066/biomedicalresearch.29-17-1223
https://doi.org/10.4066/biomedicalresearch.29-17-1223